Expansion Opportunity ALR Technologies is planning to expand facilities to Singapore in 2026, leveraging CGM Medical Singapore assets. This growth move signals openness to regional partnerships, manufacturing collaborations, and channel expansion in Southeast Asia that a sales approach could align with.

Pet CGM Growth The launch of GluCurve Pet CGM creates cross-selling potential with veterinary clinics, pet care networks, and animal health distributors. Opportunities exist to provide companion animal diabetes management solutions alongside human care offerings.

Remote Monitoring Platform ALR’s Health-e-Connect system centralizes CGM data for clinicians and Diabetes Care Facilitators, presenting a recurring revenue opportunity through subscription analytics, data integration services, and managed care facilitation for healthcare providers.

Strategic Partnerships Past and ongoing integrations, such as with Infinovo’s CGM and plans to collaborate on CGM technologies, indicate a receptivity to OEM, integration partnerships, and co-development agreements with device manufacturers and software vendors.

Mid-Market Footprint With a revenue range of 50–100 million and 11–50 employees, ALR sits in a mid-market niche ripe for scalable care-management solutions, telehealth integrations, and managed services that appeal to regional hospital networks and ambulatory clinics seeking cost-effective diabetes care.